Diagnostics & Research
The Diagnostics & Research industry has a total of 44 stocks, with a combined market cap of $913.87 billion, total revenue of $172.71 billion and a weighted average PE ratio of 50.51.
Market Cap
913.87B
Revenue
172.71B
Profits
18.09B
PE Ratio
50.51
Profit Margin
10.47%
Dividend Yield
0.19%
44 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 254.30B | 2.17% | 647,150 | 46.34B |
| 2 | DHR | Danaher Corporation | 161.39B | 2.18% | 917,626 | 25.11B |
| 3 | NTRA | Natera, Inc. | 57.51B | 1.08% | 267,241 | 2.71B |
| 4 | A | Agilent Technologies, Inc. | 49.24B | 0.38% | 166,936 | 7.37B |
| 5 | IQV | IQVIA Holdings Inc. | 43.86B | 1.71% | 97,936 | 16.98B |
| 6 | WAT | Waters Corporation | 43.27B | 0.87% | 86,687 | 4.64B |
| 7 | IDXX | IDEXX Laboratories, Inc. | 42.68B | 2.42% | 93,392 | 4.55B |
| 8 | ILMN | Illumina, Inc. | 39.77B | -3.09% | 488,983 | 4.49B |
| 9 | MTD | Mettler-Toledo International Inc. | 32.54B | 0.93% | 29,372 | 4.13B |
| 10 | DGX | Quest Diagnostics Incorporated | 26.23B | 1.79% | 98,025 | 11.56B |
| 11 | LH | Labcorp Holdings Inc. | 26.09B | 1.37% | 50,492 | 14.35B |
| 12 | GH | Guardant Health, Inc. | 22.05B | 0.79% | 183,079 | 1.18B |
| 13 | MEDP | Medpace Holdings, Inc. | 17.43B | 1.30% | 31,688 | 2.78B |
| 14 | RVTY | Revvity, Inc. | 17.02B | 0.27% | 691,532 | 2.91B |
| 15 | CRL | Charles River Laboratories International, Inc. | 14.29B | -0.89% | 101,771 | 4.00B |
| 16 | ICLR | ICON Public Limited Company | 13.10B | 0.52% | 95,843 | 8.29B |
| 17 | QGEN | Qiagen N.V. | 9.52B | 1.08% | 139,605 | 2.10B |
| 18 | GRAL | GRAIL, Inc. | 6.07B | -2.65% | 143,995 | 165.26M |
| 19 | RDNT | RadNet, Inc. | 5.57B | 2.33% | 43,686 | 2.27B |
| 20 | SHC | Sotera Health Company | 5.12B | 1.18% | 187,170 | 1.22B |
| 21 | BLLN | BillionToOne, Inc. | 4.67B | 1.14% | 79,449 | 397.41M |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 4.08B | -0.18% | 193,378 | 308.08M |
| 23 | VCYT | Veracyte, Inc. | 3.59B | 2.51% | 210,007 | 561.90M |
| 24 | CDNA | CareDx, Inc. | 3.38B | 1.04% | 221,675 | 458.09M |
| 25 | NEO | NeoGenomics, Inc. | 2.18B | 0.53% | 192,075 | 766.30M |
| 26 | WGS | GeneDx Holdings Corp. | 2.09B | 2.33% | 89,634 | 454.43M |
| 27 | PSNL | Personalis, Inc. | 1.71B | 0.57% | 818,205 | 69.67M |
| 28 | FRNM | Freenome, Inc. | 1.30B | -0.49% | 160,348 | 35.41M |
| 29 | OPK | OPKO Health, Inc. | 1.23B | 20.44% | 36,740,612 | 587.90M |
| 30 | CSTL | Castle Biosciences, Inc. | 1.02B | 0.97% | 33,420 | 357.28M |
| 31 | FLGT | Fulgent Genetics, Inc. | 580.99M | 0.50% | 15,916 | 323.93M |
| 32 | MYGN | Myriad Genetics, Inc. | 409.38M | 3.13% | 127,403 | 806.60M |
| 33 | BDSX | Biodesix, Inc. | 253.65M | 0.21% | 2,642 | 102.94M |
| 34 | XGN | Exagen Inc. | 199.86M | -2.02% | 148,665 | 71.12M |
| 35 | BNR | Burning Rock Biotech Limited | 158.72M | 3.01% | 4,089 | 73.70M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 95.23M | 4.30% | 33,205 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 91.63M | 5.83% | 99,425 | 537.08K |
| 38 | MDXH | MDxHealth SA | 57.25M | -5.02% | 98,886 | 114.02M |
| 39 | PRPO | Precipio, Inc. | 40.30M | 1.17% | 5,371 | 27.20M |
| 40 | ADVB | Advanced Biomed Inc. | 8.43M | -0.78% | 5,541 | 127.64K |
| 41 | NDRA | ENDRA Life Sciences Inc. | 7.71M | 7.64% | 5,774 | - |
| 42 | XWEL | XWELL, Inc. | 5.95M | -5.05% | 22,702 | 28.28M |
| 43 | BIAF | bioAffinity Technologies, Inc. | 4.46M | -2.25% | 34,279 | 5.90M |
| 44 | ISPC | iSpecimen Inc. | 2.49M | -2.88% | 20,370 | 466.30K |